Marcel Camps Selected Research

AGP 527

6/2022

Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcel Camps Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 04/2006
2	Melanoma (Melanoma, Malignant) 06/2022 - 01/2022
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 01/2019
1	Necrosis 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Experimental Melanoma 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Fibrosarcoma 09/2007
1	Lymphoma (Lymphomas) 09/2007

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 06/2022 - 04/2006
3	AntigensIBA 01/2022 - 09/2007
3	CytokinesIBA 01/2022 - 07/2013
3	Immunoglobulin G (IgG)IBA 01/2019 - 04/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	VaccinesIBA 01/2022 - 01/2019
2	OvalbuminIBA 01/2022 - 01/2019
2	EpitopesIBA 01/2019 - 04/2006
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 04/2006
1	Chemokine ReceptorsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	ChemokinesIBA 01/2023
1	Granzymes (Granzyme)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Natural Killer Cell ReceptorsIBA 01/2023
1	Lipid AIBA 06/2022
1	AGP 527IBA 06/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Cancer VaccinesIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	DNA VaccinesIBA 01/2019
1	Pain-FreeIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 07/2013
1	Histocompatibility Antigens Class IIBA 09/2007

Therapy/Procedure

6	Immunotherapy 01/2023 - 10/2018
5	Therapeutics 01/2023 - 07/2013
1	Intradermal Injections 06/2022